Financials
- Market Capitalization 22.82 B
- Employee 2 844
- Founded 2002
- CEO Hervé Hoppenot
- Website www.incyte.com
- Headquarter Delaware, United States
- FIGI BBG000BNPSQ9
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 518 | ROIV Roivant Sciences Ltd. - Common Shares | 34.51 USD | -4.06% | -2.73% | +14.80% | +88.48% | 24.82 B USD | ||
| 535 | INSM Insmed Incorporated - Common Stock | 109.14 USD | -5.60% | -3.60% | +10.53% | -32.65% | 23.66 B USD | ||
| 557 | UTHR United Therapeutics Corporation - Common Stock | 535.57 USD | -2.10% | -4.20% | -1.90% | +79.90% | 22.73 B USD | ||
| 573 | BNTX BioNTech SE - American Depositary Shares | 90.07 USD | -1.55% | -4.60% | -1.25% | -18.86% | 21.61 B USD |
Frequently asked questions about Incyte Corporation - Common Stock
What is the Incyte Corporation - Common Stock stock price today?
The current price of Incyte Corporation - Common Stock (INCY) is 114.23. Over the past 24 hours, the stock has changed by -2.12%. Follow the INCY chart for real-time price dynamics.
What is the stock ticker of Incyte Corporation - Common Stock?
Incyte Corporation - Common Stock trades under the ticker INCY. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Incyte Corporation - Common Stock stock going up?
INCY has changed by -2.81% over the last week, +5.79% over the last month, and +63.47% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Incyte Corporation - Common Stock net income for the last quarter?
Incyte Corporation - Common Stock reported net income of 303.33 M for the last quarter. The previous quarter showed 299.28 M, which means net income changed by +1.35%.
How many employees does Incyte Corporation - Common Stock have?
As of the latest available data, Incyte Corporation - Common Stock has 2 844 employees. Workforce size can provide additional context about the company's scale and operations.
What is Incyte Corporation - Common Stock EBITDA?
Incyte Corporation - Common Stock EBITDA is 324.92 M, and its EBITDA margin is 25.53%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Incyte Corporation - Common Stock stock?
You can buy Incyte Corporation - Common Stock (INCY) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Incyte Corporation - Common Stock stock?
Investing in Incyte Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the INCY chart and related analysis on metatrader.com as part of your research.